experimental group:Yinqi Sanhuang Decoction for Detoxification dispensing granules and entecavir treatment

2 trials

Sponsors

Hangzhou Xixi Hospital, Guang'anmen Hospital, China Academy of Chinese Medical Sciences

Conditions

Chronic hepatitis BHepatitis B-related compensatory cirrhosis

Early Phase 1

Clinical Study for Yinqi Sanhuang Decoction for Detoxificationin in Treating Chronic Hepatitis B

RecruitingChiCTR1900021521

Hangzhou Xixi HospitalChronic hepatitis B

Start: 2019-03-01Updated: 2020-03-16

Phase 3

Clinical Study for Yinqi Sanhuang Decoction for Detoxificationin Treating Hepatitis B Complicated Compensated Liver Cirrhosis

RecruitingChiCTR1900021532

Guang'anmen Hospital, China Academy of Chinese Medical SciencesHepatitis B-related compensatory cirrhosis

Start: 2019-03-01Updated: 2020-03-16

Related Papers

YinQiSanHuang Jiedu decoction for the treatment of hepatitis B-related compensated liver cirrhosis: study protocol for a multi-center randomized controlled trial.

2021-10-142 citations

Efficacy and safety of YinQiSanHuang-antiviral decoction in chronic hepatitis B: study protocol for a randomized, placebo-controlled, double-blinded trial.

2020-06-053 citations